Suchergebnisse - "Verweij, Paul E."

PubPharm (567)

81

ISO standard 20776-1 or serial 2-fold dilution for antifungal susceptibility plate preparation : that is the question!

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Arendrup, M. | Jørgensen, K. | Hanemaaijer, N. | +1

82

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU) : a randomised, open-label, proof-of-concept trial

enthalten in: Intensive care medicine | 2021

von Vanderbeke, L. | Janssen, N. | Bergmans, D. | +37

CommentIn: Intensive Care Med. 2021 Nov;47(11):1341-1342. - PMID 34374834

83

Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply

enthalten in: The Lancet. Infectious diseases | 2021

von Koehler, P. | White, P. | Verweij, P. | +1

CommentOn: Lancet Infect Dis. 2021 Jun;21(6):e149-e162. - PMID 33333012

84

Fungal infections should be part of the core outcome set for COVID-19

enthalten in: The Lancet. Infectious diseases | 2021

von Verweij, P. | Alanio, A.

CommentIn: Lancet Infect Dis. 2021 Jun;21(6):e146. - PMID 33301729

85

Defining and managing COVID-19-associated pulmonary aspergillosis : the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

enthalten in: The Lancet. Infectious diseases | 2021

von Koehler, P. | Bassetti, M. | Chakrabarti, A. | +33

CommentIn: Lancet Infect Dis. 2021 Jun;21(6):767-769. - PMID 33662323

86

Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021

enthalten in: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2021

von Buil, J. | van Zanten, A. | Bentvelsen, R. | +10

87

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

enthalten in: Intensive care medicine | 2021

von Vanderbeke, L. | Janssen, N. | Bergmans, D. | +29

88

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

enthalten in: Intensive care medicine | 2021

von Vanderbeke, L. | Janssen, N. | Bergmans, D. | +29

89

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

enthalten in: Intensive care medicine | 2021

von Vanderbeke, L. | Janssen, N. | Bergmans, D. | +29

90

Selective Flamingo Medium for the Isolation of Aspergillus fumigatus

enthalten in: Microorganisms | 2021

von Zhang, J. | Debets, A. | Verweij, P. | +1